DENSO CORPORATION

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

otctrader

Rank: Vice President [?]

Points: 1430 [?]

Votes: 34 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

DENSO CORPORATION

posted on Sep 10, 2007 06:47PM

Jul 26, 2007

DENSO Announces First-quarter Financial Results

-Global Consolidated Net Sales Rise 15 percent-

KARIYA (Japan) DENSO Corporation today announced global financial results for the first quarter ended June 30, 2007:

•	Consolidated net sales totaled 984.3 billion yen (US$8.0 billion), a 15 percent increase from the first quarter of last term.
•	Consolidated operating income totaled 93.3 billion yen (US$757.2 million), a 13.1 percent increase from the first quarter of last term.
•	Consolidated net income totaled 67.3 billion yen (US$546.3 million), a 15 percent increase from the first quarter of last term.

"Sales growth was mainly due to the increase in overseas car production for Japanese auto manufacturers", said Koji Kobayashi, senior managing director of DENSO Corporation. "In spite of high raw material costs and an increase in depreciation costs, increased production volume and foreign exchange gain led to an increase in operating income."